184 related articles for article (PubMed ID: 11044106)
1. Expression of the two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant Venezuelan equine encephalitis virus replicon particles.
Balasuriya UB; Heidner HW; Hedges JF; Williams JC; Davis NL; Johnston RE; MacLachlan NJ
J Virol; 2000 Nov; 74(22):10623-30. PubMed ID: 11044106
[TBL] [Abstract][Full Text] [Related]
2. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
[TBL] [Abstract][Full Text] [Related]
3. Alphavirus replicon particles expressing the two major envelope proteins of equine arteritis virus induce high level protection against challenge with virulent virus in vaccinated horses.
Balasuriya UB; Heidner HW; Davis NL; Wagner HM; Hullinger PJ; Hedges JF; Williams JC; Johnston RE; David Wilson W; Liu IK; James MacLachlan N
Vaccine; 2002 Feb; 20(11-12):1609-17. PubMed ID: 11858869
[TBL] [Abstract][Full Text] [Related]
4. Increased immunogenicity of a DNA-launched Venezuelan equine encephalitis virus-based replicon DNA vaccine.
Ljungberg K; Whitmore AC; Fluet ME; Moran TP; Shabman RS; Collier ML; Kraus AA; Thompson JM; Montefiori DC; Beard C; Johnston RE
J Virol; 2007 Dec; 81(24):13412-23. PubMed ID: 17913817
[TBL] [Abstract][Full Text] [Related]
5. Large envelope glycoprotein and nucleocapsid protein of equine arteritis virus (EAV) induce an immune response in Balb/c mice by DNA vaccination; strategy for developing a DNA-vaccine against EAV-infection.
Tobiasch E; Kehm R; Bahr U; Tidona CA; Jakob NJ; Handermann M; Darai G; Giese M
Virus Genes; 2001 Mar; 22(2):187-99. PubMed ID: 11324756
[TBL] [Abstract][Full Text] [Related]
6. Heterologous gene expression from transmissible gastroenteritis virus replicon particles.
Curtis KM; Yount B; Baric RS
J Virol; 2002 Feb; 76(3):1422-34. PubMed ID: 11773416
[TBL] [Abstract][Full Text] [Related]
7. Effects of rapid antigen degradation and VEE glycoprotein specificity on immune responses induced by a VEE replicon vaccine.
Fluet ME; Whitmore AC; Moshkoff DA; Fu K; Tang Y; Collier ML; West A; Moore DT; Swanstrom R; Johnston RE; Davis NL
Virology; 2008 Jan; 370(1):22-32. PubMed ID: 17904185
[TBL] [Abstract][Full Text] [Related]
8. Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles.
Harrington PR; Yount B; Johnston RE; Davis N; Moe C; Baric RS
J Virol; 2002 Jan; 76(2):730-42. PubMed ID: 11752163
[TBL] [Abstract][Full Text] [Related]
9. Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus.
Sheahan T; Whitmore A; Long K; Ferris M; Rockx B; Funkhouser W; Donaldson E; Gralinski L; Collier M; Heise M; Davis N; Johnston R; Baric RS
J Virol; 2011 Jan; 85(1):217-30. PubMed ID: 20980507
[TBL] [Abstract][Full Text] [Related]
10. An immunogenic and protective alphavirus replicon particle-based dengue vaccine overcomes maternal antibody interference in weanling mice.
White LJ; Parsons MM; Whitmore AC; Williams BM; de Silva A; Johnston RE
J Virol; 2007 Oct; 81(19):10329-39. PubMed ID: 17652394
[TBL] [Abstract][Full Text] [Related]
11. An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector.
Perri S; Greer CE; Thudium K; Doe B; Legg H; Liu H; Romero RE; Tang Z; Bin Q; Dubensky TW; Vajdy M; Otten GR; Polo JM
J Virol; 2003 Oct; 77(19):10394-403. PubMed ID: 12970424
[TBL] [Abstract][Full Text] [Related]
12. Generation of a candidate live marker vaccine for equine arteritis virus by deletion of the major virus neutralization domain.
Castillo-Olivares J; Wieringa R; Bakonyi T; de Vries AA; Davis-Poynter NJ; Rottier PJ
J Virol; 2003 Aug; 77(15):8470-80. PubMed ID: 12857916
[TBL] [Abstract][Full Text] [Related]
13. Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus.
Pushko P; Bray M; Ludwig GV; Parker M; Schmaljohn A; Sanchez A; Jahrling PB; Smith JF
Vaccine; 2000 Aug; 19(1):142-53. PubMed ID: 10924796
[TBL] [Abstract][Full Text] [Related]
14. Improved protection against Venezuelan equine encephalitis by genetic engineering of a recombinant vaccinia virus.
Bennett AM; Lescott T; Phillpotts RJ
Viral Immunol; 1998; 11(3):109-17. PubMed ID: 9918402
[TBL] [Abstract][Full Text] [Related]
15. Development of a Broadly Accessible Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Platform.
Agnihothram S; Menachery VD; Yount BL; Lindesmith LC; Scobey T; Whitmore A; Schäfer A; Heise MT; Baric RS
J Virol; 2018 Jun; 92(11):. PubMed ID: 29540599
[TBL] [Abstract][Full Text] [Related]
16. Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge.
Kinney RM; Esposito JJ; Mathews JH; Johnson BJ; Roehrig JT; Barrett AD; Trent DW
J Virol; 1988 Dec; 62(12):4697-702. PubMed ID: 3184276
[TBL] [Abstract][Full Text] [Related]
17. Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats.
Mok H; Lee S; Utley TJ; Shepherd BE; Polosukhin VV; Collier ML; Davis NL; Johnston RE; Crowe JE
J Virol; 2007 Dec; 81(24):13710-22. PubMed ID: 17928349
[TBL] [Abstract][Full Text] [Related]
18. DNA vaccines co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus (PRRSV) display enhanced immunogenicity.
Jiang Y; Xiao S; Fang L; Yu X; Song Y; Niu C; Chen H
Vaccine; 2006 Apr; 24(15):2869-79. PubMed ID: 16446016
[TBL] [Abstract][Full Text] [Related]
19. Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector.
Caley IJ; Betts MR; Irlbeck DM; Davis NL; Swanstrom R; Frelinger JA; Johnston RE
J Virol; 1997 Apr; 71(4):3031-8. PubMed ID: 9060663
[TBL] [Abstract][Full Text] [Related]
20. Detection of antibodies to equine arteritis virus by enzyme linked immunosorbant assays utilizing G(L), M and N proteins expressed from recombinant baculoviruses.
Hedges JF; Balasuriya UB; Ahmad S; Timoney PJ; McCollum WH; Yilma T; MacLachlan NJ
J Virol Methods; 1998 Dec; 76(1-2):127-37. PubMed ID: 9923747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
